| 000 | 01643 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517050044.0 | ||
| 264 | 0 | _c20161102 | |
| 008 | 201611s 0 0 eng d | ||
| 022 | _a1523-4681 | ||
| 024 | 7 |
_a10.1002/jbmr.2693 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Xiaoyan | |
| 245 | 0 | 0 |
_aOsteonecrosis of the Jaw in the United States Food and Drug Administration's Adverse Event Reporting System (FAERS). _h[electronic resource] |
| 260 |
_bJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research _cFeb 2016 |
||
| 300 |
_a336-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdverse Drug Reaction Reporting Systems |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBisphosphonate-Associated Osteonecrosis of the Jaw _xepidemiology |
| 650 | 0 | 4 | _aDatabases, Factual |
| 650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteoporosis _xdrug therapy |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 700 | 1 | _aHamadeh, Issam S | |
| 700 | 1 | _aSong, Shuang | |
| 700 | 1 | _aKatz, Joseph | |
| 700 | 1 | _aMoreb, Jan S | |
| 700 | 1 | _aLangaee, Taimour Y | |
| 700 | 1 | _aLesko, Lawrence J | |
| 700 | 1 | _aGong, Yan | |
| 773 | 0 |
_tJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research _gvol. 31 _gno. 2 _gp. 336-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jbmr.2693 _zAvailable from publisher's website |
| 999 |
_c25183464 _d25183464 |
||